AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BlueLinx Holdings Inc.

Regulatory Filings May 25, 2022

Preview not available for this file type.

Download Source File

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of report (Date of earliest event reported): May 25, 2022 (May 19, 2022)

BlueLinx Holdings Inc .

(Exact name of registrant specified in its charter)

Delaware 001-32383 77-0627356
(State or other (Commission (I.R.S. Employer
jurisdiction of incorporation) File Number) Identification No.)
1950 Spectrum Circle , Suite 300 , Marietta , GA 30067
(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code: ( 770 ) 953-7000


(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 under the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per share BXC New York Stock Exchange

Item 5.07 Submission of Matters to a Vote of Security Holders

On May 19, 2022, BlueLinx Holdings Inc. (the “Company”) held its Annual Meeting of Stockholders (the “2022 Annual Meeting”) to (1) elect six directors to hold office until the Company’s 2023 Annual Meeting of Stockholders or until their successors are duly elected and qualified; (2) ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the Company’s current fiscal year ending December 31, 2022; and (3) approve a non-binding, advisory resolution regarding the executive compensation described in the Company’s Proxy Statement for the 2022 Annual Meeting.

At the close of business of March 25, 2022, the record date for the 2022 Annual Meeting, an aggregate of 9,731,459 shares of the Company’s common stock were issued and outstanding. At the meeting, 7,627,146 shares of common stock were represented in person or by proxy; therefore, a quorum was present.

At the 2022 Annual Meeting, the Company’s stockholders voted as follows:

(1) For the election of the below-named nominees to the Board of Directors of the Company:

Nominees Number of Votes For Number of Votes Withheld Broker Non-Votes
Dominic DiNapoli 5,480,456 495,139 1,651,551
Kim S. Fennebresque 5,710,463 265,132 1,651,551
Dwight Gibson 5,914,419 61,176 1,651,551
Mitchell B. Lewis 5,754,306 221,289 1,651,551
J. David Smith 5,666,062 309,533 1,651,551
Carol B. Yancey 5,767,672 207,923 1,651,551

(2) For the ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the Company’s current fiscal year ending December 31, 2022:

For Against Abstain
7,620,778 5,120 1,248

(3) For the approval of the non-binding, advisory resolution regarding the executive compensation described in the Company’s Proxy Statement for the 2022 Annual Meeting:

For Against Abstain Broker Non-Votes
5,672,112 295,629 7,854 1,651,551

Accordingly, the Company’s stockholders elected the six director nominees and approved proposals 2 and 3 at the 2022 Annual Meeting.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits:

The following exhibits are attached with this Current Report on Form 8-K:

Exhibit No. Exhibit Description
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BlueLinx Holdings Inc. — /s/ Shyam K. Reddy
Shyam K. Reddy
Chief Legal and Sustainability Officer

Talk to a Data Expert

Have a question? We'll get back to you promptly.